Real-time elastography for differentiation of breast lesions by Yılmaz, Ebru et al.
Real-Time Elastography for Differentiation of Breast 
Lesions
Ebru Yılmaz1ABCDEF, Ayhan Yılmaz2AB, Ahmet Aslan3CDEF, Ibrahim Inan4CDEF, 
Mujgan Calıskan Evren5BD, Kemal Tekesin6BF
1 Department of Radiology, Gaziosmanpaşa Taksim Training and Research Hospital, Istanbul, Turkey
2 Department of Radiology, Bezmialem Vakif University Hospital, Istanbul, Turkey
3 Department of Radiology, Medical School of Istanbul, Medeniyet University, Istanbul, Turkey
4 Department of Radiology, Adıyaman University Hospital, Adıyaman, Turkey
5 Department of General Surgery, Medipol University Hospital, Istanbul, Turkey
6 Department of General Surgery, Uskudar State Hospital, Istanbul, Turkey
Author’s address: Ebru Yılmaz, Department of Radiology, Gaziosmanpaşa Taksim Training and Research Hospital, Postal 
code: 34380. Şişli, Istanbul, Turkey, e-mail: ebruyilmaz99@yahoo.com
 Summary
 Backroung: To investigate the diagnostic performance of the elastography-based strain index ratio in the 
differential diagnosis of malignant and benign breast lesions.
 Material/Methods: Seventy-nine breast masses that were classified as BI-RADS category 3, 4, and 5 on B-mode 
ultrasonography (US) were further prospectively evaluated by real-time sonoelastography (RTE). To 
obtain an optimal cut-off value of the strain ratio for differentiating between malignant and benign 
breast lesions, RTE findings were compared with histopathology of core needle biopsy samples or 
with ultrasound follow-up data of the analyzed masses.
 Results: Seventy-nine breast lesions [BI-RADS category 3 (n=15), BI-RADS category 4 (n=34), and BI-RADS 
category 5 (n=30)] were classified as malignant (n=36) or benign (n=43). The mean strain index 
value was 6.59±3.44 (range 0.6–14) for malignant lesions and 2.79±2.16 (range 0.6–8.7) for benign 
lesions, respectively (p<0.05). As regards the detection of malignant lesions, US was characterized 
by sensitivity and specificity of 100% (CI 95%; 88–100) and 90% (CI 95%; 76–97), respectively. When 
an optimal value of the strain ratio (4.25) was obtained by ROC curve analysis, the sensitivity and 
specificity for diagnosing malignant lesions were 86% (CI 95%; 70–95) and 76% (CI 95%; 60–87), 
respectively.
 Conclusions: RTE can play an important role in the differentiation between malignant and benign breast masses, 
but it should be used in conjunction with ultrasonography.
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Backround
Breast biopsy is the best diagnostic test for diagnosing sus-
picious breast lesions. However, it has been reported that 
75% of biopsied breast lesions are benign on histopathol-
ogy [1,2]. Therefore, it is crucial to look for methods that 
will help avoid unnecessary biopsies that can lead to com-
plications, patient anxiety, and unnecessary costs.
Ultrasound (US) imaging is a valuable method for diag-
nosing breast cancer, and it is complementary to mam-
mography. It effectively demonstrates lesions that are not 
identified on mammography due to dense parenchyma, 
and it characterizes lesions that are not well-demarcated 
on mammography. However, a high proportion of benign 
lesions that are diagnosed on histopathology underscores 
the need for more sensitive and specific tools that could 
decrease the number of biopsied lesions. In recent years, 
elastography has shown some promise in that respect. 
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There are two main sonoelastography methods described 
in the current literature, i.e., (1) strain and (2) shear-wave 
sonoelastography. In shear-wave sonoelastography, shear 
waves are sent from an ultrasound probe to the analyzed 
tissue, and the speed of wave propagation is calculated. 
This method outputs quantitative data, and it is not influ-
enced by the pressure applied to the probe. In strain sonoe-
lastography, pressure is conveyed from the transducer to 
the tissue at short time intervals, and the resulting tissue 
deformation is encoded and represented as a color map 
(pattern of elastography). In strain sonoelastography, a 
strain ratio can be calculated as a quantitative measure.
In prior studies, elastography has been used to character-
ize suspicious breast lesions, with greater sensitivity and 
specificity (41.0–98.5%) than B-mode US (7.1–98.8%) [3,4]. 
However, these studies have used only real-time elastog-
raphy (RTE) to characterize breast lesions, and there is 
scarce evidence on the utility of the strain ratio. The cur-
rent study was performed to investigate the diagnostic per-
formance of the strain index ratio in characterizing breast 
lesions as malignant or benign.
Material and Methods
Study design
The local ethics committee approved the prospective design 
of the study, and written informed consent was collected 
from all patients who were included in the study.
Patient group
The study was performed between February 2011 and May 
2013 in consecutive patients who met all inclusion criteria 
and no exclusion criteria. The inclusion criteria were as fol-
lows: (1) presence of a mass in category 3, 4, 5 of the Breast 
Imaging Reporting and Data Systems (BI-RADS) as assessed 
by mammography and B-mode US; (2) availably of histo-
pathologic diagnosis (tru-cut needle biopsy or surgery) or 
stable follow-up every six months for two years. Exclusion 
criteria were as follows: (1) lack of consent to enter the 
study, (2) presence of lesions smaller than 4 mm or greater 
than 5 cm. Data such as age, number of masses, BI-RADS 
category, and the longest dimension (cm) were noted.
BI-RADS classification
Lesions were categorized on B-mode US (scanner LOGIQ 
E9; GE Healthcare, Milwaukee, WI, USA) according to the 
BI-RADS classification (2013 edition) [5]. Shape, margin, 
orientation relative to the plane of skin, echo patterns, 
posterior acoustic shadowing, and other features of the 
masses were evaluated. Ovoid, well-circumscribed, hypo-
echoic, non-palpable masses that had a parallel orientation 
to the skin were categorized as BI-RADS category 3, if the 
patient had no risk factors and was younger than 40 years. 
Follow-up at six-month intervals was planned for those 
patients for at least two years. The patients who had at 
least one suspicious finding for malignancy, such as irregu-
lar contour, microlobulation, angulation, vertical orienta-
tion to the skin, posterior acoustic shadowing, echogenic 
halo, or abnormal findings in the surrounding tissue were 
categorized as BI-RADS category 4 (moderately suspicious 
for malignancy) and 5 (strongly suspicious for malignancy), 
and histopathologic assessment was performed. The mass-
es that demonstrated at least three suspicious findings for 
malignancy were classified as BI-RADS category 5. Lesions 
that could not be categorized as BI-RADS category 3 or 5 
were included in BI-RADS category 4 [6]. BI-RADS catego-
ry 4 lesions were further grouped into BI-RADS category 
4a, 4b, and 4c [5]. BI-RADS category 3 and 4a lesions were 
considered as benign, and BI-RADS category 4b, 4c, and 
5 lesions were considered as malignant. These data were 
compared with histopathological and follow-up findings to 
calculate sensitivity, specificity, positive and negative pre-
dictive values, and accuracy.
Real-time elastography
After B-mode US examinations, a digital sonography scan-
ner (LOGIQ E9; GE Healthcare, Milwaukee, WI, USA) 
equipped with RTE software and a linear 12–15 MHz mul-
tifrequency transducer was used, and the same probe was 
applied with the freehand manual compression technique. 
A different radiologist acquired RTE findings after assess-
ment of the data of B-mode ultrasonography. The B-mode 
and elastography images were seen on the same screen. 
During the elastography examination, the images were 
displayed over the B-mode images on a color scale [7,8]. 
Attention was paid to include the lesion with the sur-
rounding fatty tissue in the elastographic box. The probe 
was maintained parallel to the chest wall during freehand 
manual compression and decompression. The compres-
sion quality factor was used (bar scale from 1 to 7), and 
the images were obtained when optimal compression was 
between the bar values of 5 and 7. Static and moving 
images were also recorded digitally on the local sonogra-
phy device for later review. The strain ratio was measured 
by comparing the breast lesion to the adjacent fatty tissue. 
The first region of interest (ROI) of 0.1 cm2 was placed in 
the adjacent fatty tissue that was more superficial than the 
lesion. The second ROI was placed within the mass. The 
strain ratio was then automatically computed by the US 
machine [9]. For the lesions that had dimensions greater 
than 5 mm, measurement was performed with more than 
one ROI, and then the mean value was calculated. The 
measurement was performed with one ROI for lesions 
smaller than 5 mm (Figures 1, 2).
Diagnostic criteria
All breast lesions included in the study were classified as 
benign or malignant according to histopathologic or ultra-
sound follow-up findings. A US-guided core-needle biopsy 
was performed with a 14-gauge automatic Tru-Cut biop-
sy needle (Bard Biopsy Systems, Tempe, AZ) in patients 
with BI-RADS category 4 and 5 lesions within a week of 
the radiologic assessment by an interventional radiolo-
gist blinded to the US and RTE findings. In patients with 
lesions classified as BI-RADS category 3, at least a two-year 
follow-up at six-month intervals was carried out. However, 
core biopsies were performed in 4 patients with BI-RADS 
category 3 lesions due to the clinician’s or patients’ request. 
Moreover, one biopsy was not carried out for a category 4 
of BI-RADS lesion because of patient’s refusal. The patient 
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was informed of possible risks associated with the lesion, 
and follow-up was recommended.
Statistical analysis
Breast lesions were classified as malignant or benign, and 
RTE findings were compared. The one-sample Kolmogorov-
Smirnov test was used for assessing normality. The vari-
ables were expressed as means with standard deviations, 
minimum and maximum values. A receiver operating char-
acteristic curve was performed to obtain an optimal cut-off 
value of the strain ratio. Diagnostic test values (sensitivity, 
specificity, positive predictive value, negative predictive 
value, accuracy) with respective 95% confidential intervals 
were calculated. A p value <0.05 was considered signifi-
cant, and analysis was bidirectional. NCSS 10 software was 
used for statistical analysis.
Results
Seventy-nine breast lesions that were found in 75 patients 
were included in the study. Twenty-eight of these patients 
were younger than 40 years, and ultrasound was per-
formed in them as first-line imaging method. US examina-
tions were performed in 47 patients older than 40 years 
after mammography due to dense breast tissue or detec-
tion of pathologic findings prompting sonographic exami-
nation. Based on US findings, the lesions were classi-
fied as BI-RADS category 3 (n=15), BI-RADS category 4 
(n=34; twenty-two of them were 4a, seven of them were 
4b, and five of them were 4c), and BI-RADS category 5 
(n=30). US-guided core needle biopsy was performed in 
67 lesions with BI-RADS category 3, 4, and 5. One patient 
with BI-RADS category 4 lesion did not agree to biopsy, 
and in this case follow-up was recommended. Moreover, 
four patients who had BI-RADS category 3 lesions demand-
ed biopsy instead of follow-up and therefore core biopsy 
was performed. After at least 24 months of US-based fol-
low-up, no morphologic changes occurred in BI-RADS 
category 3 lesions (n=11) and BI-RADS category 4 lesion 
(n=1) (Table 1).
Forty-three lesions were classified as benign, and 36 
lesions were classified as malignant, according to the 
Figure 1.  A 15×11 mm mass with irregular 
margins and a strain index ratio of 11. 
The histopathological diagnosis was 
invasive ductal cancer.
Figure 2.  A hypoechoic, 10×5 mm, mass 
perpendicular to the skin. The strain 
index ratio was 4.7. The histopathological 
findings confirmed the diagnosis of 
invasive ductal cancer.
B-mode US evaluation Histopathological evaluation
BI-RADS category Benignn: 43; 54%
Malign
n: 36; 46%
5 –  30 (38%)
4  28 (35%)  6 (8%)
3  15 (19%) –
Table 1.  Distribution of benign and malignant lesions, according 
to histopathological results and follow-up. (BI-RADS 
classification).
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histopathological assessment and follow-up findings. The 
mean age was 50±12.3 years for patients with malignant 
lesions and 35.51±13.60 years for patients with benign 
lesions (range of 16–78 years). Histopathological exami-
nations revealed 36 malignant lesions that included inva-
sive ductal carcinoma (n=29), invasive lobular carcinoma 
(n=3), mucinous carcinoma (n=1), ductal carcinoma in situ 
(n=1), malignant phyllodes tumor (n=1), and a metastatic 
lesion from lung carcinoma (n=1). Thirty-one lesions were 
benign and included fibroadenomas (n=12), tubular adeno-
ma (n=1), pseudoangiomatous stromal hyperplasia (n=1), 
benign phyllodes tumor (n=2), papillary lesion (n=2), aden-
osis (n=4), fat necrosis (n=2), fibrocystic disease (n=2), and 
granulomatous mastitis (n=5). The remaining 12 lesions 
remained stable (accepted as benign) after a 2-year follow-
up that was performed every six months.
All lesions in the BI-RADS category 4c and 5 were diag-
nosed as malignant after histopathological assessment. 
Additionally, one BI-RADS category 4b lesion (14.2%) was 
malignant.
The mean value of the strain ratio of the malignant lesions 
was 6.59±3.44 (range 0.6–14), and the mean strain ratio 
value of the benign lesions was 2.79±2.16 (range 0.6–8.7) 
(p < 0.05). When 4.25 was used as a threshold value to dif-
ferentiate between malignant and benign lesions, the sen-
sitivity of elastography was 86% (CI 95%; 70–95), and its 
specificity was 76% (CI 95%; 60–87). The sensitivity of US 
was 100% (CI 95%;88–100), and its specificity was 90% (CI 
95%; 76–97) (Table 2).
Discussion
It has been known for centuries that palpation of the breast 
is a very effective method for detecting abnormal masses, 
with hardness being an indicator of malignancy. Based 
on this basic principle, elastography has been developed. 
Elastography is a sonographic imaging technique that pro-
vides qualitative and quantitative data by comparing hard-
ness of the target tissue and that of the adjacent tissues. In 
our study, 79 breast lesions were evaluated by RTE, and 
strain ratios were calculated for each lesion to assess diag-
nostic accuracy of RTE. We found that RTE is useful, but it 
should be used in conjunction with US.
Two, two different elastographic methods have been used. 
The first one is strain elastography in which tissue dis-
placement is estimated with the freehand compression 
technique (short-term compression applied to the tissue 
with the transducer) and represented by a (strain) color 
map and digital data [10]. Hard tissues are subject to small 
deformations, in contrast to soft tissues that often undergo 
substantial deformation. In malignant lesions, elasticity is 
lower due to the increased hardness and resultant small-
er deformation. In the shear-wave elastography, which is 
another method of evaluating elasticity, shear waves are 
sent from the transducer, and their propagation speed is 
calculated. This approach is independent of the pressure 
that has been applied to the probe and provides quantita-
tive data [11]. Recent studies show that there is no signifi-
cant difference between these two methods for the diagno-
sis of competence [12].
In the evaluation of the strain elastography data, a scoring 
technique according to a specific color is used (Ueno scor-
ing) [13]. This scoring is a qualitative evaluation. The color 
coding can vary depending on the device. A color map is 
created according to tissue elasticity values. On color maps, 
blue represents hard tissues, while red represents soft tis-
sues. During elastographic examinations, color-coded imag-
es are displayed over B-mode images [7,8]. Similarly to all 
ultrasound techniques, operator dependency is also a lim-
itation of elastographic evaluations [14,15]. In our study, 
we evaluated quantitative data (strain index ratio) which is 
easy to obtain and represents a more objective measure of 
tissue elasticity than color-coding.
In the study performed by Yerli et al., the mean strain 
index value of benign lesions was 2.69±0.59, and the mean 
strain index value of malignant lesions was 3.75±0.68 [16]. 
The specificity of RTE was 93% at a threshold value 
of 3.52, while the specificity of US was 73%. [16]. In the 
study by Ueno et al., the cut-off value of the strain ratio 
was 4.8 [17]. Similarly, Chio et al. reported that the strain 
ratios were 2.63±4.57 for benign lesions and 6.57±6.62 
for malignant lesions, and this difference was significant 
[17]. In the same study, the optimal threshold value of the 
strain ratio with the highest sensitivity and specificity 
(95% and 75%, respectively) was 2.24. The threshold value 
was higher in Ueno’s study, perhaps because of a differ-
ent placement of ROIs within the adipose tissue and dif-
ferences in lesion characteristics. Additionally, because the 
degree of compression can change depending on the depth, 
the strain ratio value can also vary with different points 
of reference [17–20]. In our study, the threshold value was 
4.25, which is similar to that reported by Ueno et al. In our 
study, ROIs were not at the same depth as the lesion (ROIs 
Ultrasonography Real-time elastography 
Sensitivity (CI 95%)  100% (0.88–1)  86% (0.70–0.95)
Specificity (CI 95%)  90% (0.76–0.97)  76% (0.60–0.87)
PPV (CI 95%)  90% (0.76–0.97)  76% (0.60–0.87)
NPV (CI 95%)  100% (0.89–1)  86% (0.70–0.95)
Accuracy (CI 95%)  95%  81%
Table 2. Comparison of US and RTE.
US – ultrasonography, RTE – real time elastography, CI – confidence interval, PPV – positive predictive value, NPV – negative predictive value.
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were placed superficially in fatty tissues). Nevertheless, 
the difference between the strain index ratio of benign and 
malignant lesions was statistically significant in our study.
In our study, we found that the average strain ratio of 
malignant lesions was 6.59±3.44 (range 0.6–14), and the 
average strain ratio of benign lesions was 2.79±2.16 (range 
0.6–8.7) (p<0.05). When 4.25 was used as the threshold 
value, the sensitivity of RTE was 86%, and the specific-
ity of RTE was 76%. The sensitivity of US was 100%, and 
its specificity was 90%. In our department, ultrasonogra-
phy is routinely performed in all patients younger than 
40 years or in patients who have dense breast tissue on 
mammography. The high sensitivity and specificity val-
ues of ultrasonography may be due to our high experience. 
However, lower sensitivity and specificity of RTE in com-
parison to US can be caused by inherent limitations of RTE. 
Nevertheless, we found that sonoelastography provides 
additional information for BI-RADS category 4a lesions, 
and follow-up may be a better option instead of biopsy for 
the lesions that have a lower strain index value than the 
applied threshold.
False negative and false positive cases in our study reduced 
the sensitivity (86%) and specificity (76%) of RTE. Twelve 
lesions (two benign phyllodes tumors, two intraductal pap-
illomas, one tubular adenoma, one adenosis, six fibroade-
nomas) with a strain index ratio higher than 4.25 were con-
sidered false positive. Additionally, five BI-RADS category 
5 lesions (four invasive ductal carcinomas, one invasive 
lobular carcinoma) had a strain index ratio lower than the 
threshold value. Furthermore, in three cases with BI-RADS 
category 4b (one adenosis, one fat necrosis, one fibrosis), 
strain index ratios were markedly lower than the thresh-
old value (they were 1.0, 1.1, and 2.1, respectively). There 
was only one case that was considered malignant with 
both US and RTE (categorized as BI-RADS category 4b on 
US and with strain index ratio of 7.0), but histopathologi-
cal assessment revealed a benign fibroadenoma. Sixteen 
of 22 lesions which were categorized as BI-RADS catego-
ry 4a on US and therefore considered as benign had strain 
index ratios lower than the threshold value. In the remain-
ing six patients (one adenosis, two benign phyllodes, two 
fibroadenomas, one tubular adenoma), strain index ratios 
were higher than the threshold value. Therefore, strain 
index ratios, in addition to US data, may have provided 
additional information for 16 lesions in BI-RADS catego-
ry 4a, so that these lesions could have been downgraded 
to BI-RADS category 3 lesions that do not require biopsy 
[4,15,21]. However, based on our data, biopsy is necessary 
for all BI-RADS category 4b, 4c, and 5 lesions regardless of 
the strain index ratio.
There are some limitations of our study. First, sonoelas-
tography is dependent on the experience of the radiologist. 
Moreover, differences in density in breast tissues adjacent 
to the breast lesions affect elasticity values [22]. Another 
limitation is that intra-observer or inter-observer variabil-
ity was not taken into account.
Conclusions
In conclusion, elastography is an important modality that 
can provide additional information in the diagnosis of 
breast lesions. However, the information provided by RTE 
alone is limited, and for breast lesions it should be inter-
preted in combination with US findings.
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